Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials
European Journal of Cancer2019Vol. 112, pp. 98–106
Citations Over TimeTop 10% of 2019 papers
Sheri L. Spunt, Nadine Francotte, Gian Luca De Salvo, Yueh-Yun Chi, Ilaria Zanetti, Andrea Hayes‐Jordan, Simon C. Kao, Daniel Orbach, Bernadette Brennan, Aaron R. Weiss, Max M. van Noesel, Lynn Million, Rita Alaggio, David M. Parham, Anna Kelsey, R. Lor Randall, M. Beth McCarville, Gianni Bisogno, Douglas S. Hawkins, Andrea Ferrari
Related Papers
- → Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients(2022)3 cited
- → A phase I–II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma(1988)40 cited
- → 67P Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced soft tissue sarcoma: A single-arm phase II trial(2021)2 cited
- → Single-Agent Doxorubicin versus Doxorubicin Plus Ifosfamide in Advanced Soft Tissue Sarcoma(2012)
- [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].(2002)